Bo R. Rueda, Ph.D.
Associate Professor, Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Associate Director, Vincent Center for Reproductive Biology, Massachusetts General Hospital
Contact Info
Bo Rueda
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Mailstop: THR 901A
Phone: 617-724-2825
Fax: 617-726-0561
brueda@partners.org
Administrative Assistant
Obstetrics and Gynecology
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Phone: 617-724-2402
Fax: 617-726-0561
sgilligan@partners.org
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Mailstop: THR 901A
Phone: 617-724-2825
Fax: 617-726-0561
brueda@partners.org
Assistant
Sean GilliganAdministrative Assistant
Obstetrics and Gynecology
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Phone: 617-724-2402
Fax: 617-726-0561
sgilligan@partners.org
DF/HCC Program Affiliation
Gynecologic CancerResearch Abstract
In collaboration with Dr. Lawrence Zukerberg (MGH Department of Pathology), we have identified a protein that is lost with high frequency in endometrial and ovarian carcinoma. The protein, known as Cables, is a negative regulator of the cell cycle via its ability to enhance the inhibitory phosphorylation of the Cdk2 protein (a key modulator of the G1-S phase transition in mitosis). Consequently, loss of function would theoretically result in uncontrolled cellular proliferation as a first step towards cancer. We have completed studies showing that this cell cycle regulatory protein is regulated by hormones in human endometrial epithelial cells. We observe a consistent loss of this protein in almost all endometrial cancer biopsies and, most importantly, intermittent loss of the protein in those biopsies with pre-cancerous atypical hyperplasia. In addition, we have generated a gene mutant mouse, which is deficient in this cell cycle regulatory protein. Cables mutant mice have evidence of endometrial hyperplasia at an early age and develop endometrial cancer following exposure to chronic estrogen. This finding served as the impetus to evaluate Cables expression in human ovarian cancer. Similar to that which is observed in human endometrial cancer samples, there is a significant loss of nuclear Cables expression associated with human ovarian serous and endometrioid cancer. The functional significance of Cables as a tumor suppressor in the ovary is currently being explored.Publications
- Lee HJ, Sakamoto H, Luo H, Skaznik-Wikiel ME, Friel AM, Niikura T, Tilly JC, Niikura Y, Klein R, Styer AK, Zukerberg LR, Tilly JL, Rueda BR.Loss of CABLES1, a cyclin-dependent kinase-interacting protein that inhibits cell cycle progression, results in ger
17912041 - Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR.Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (
16825198




